J Tavakkoly-Bazzaz
Overview
Explore the profile of J Tavakkoly-Bazzaz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
105
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Maheronnaghsh M, Niktab I, Enayati S, Amoli M, Hosseini S, Tavakkoly-Bazzaz J
Nutr Metab Cardiovasc Dis
. 2021 Mar;
31(4):1137-1147.
PMID: 33712363
Background And Aims: In-stent restenosis (ISR) remains the most daunting challenge of current treatments of coronary artery disease (CAD). MicroRNAs (miRNAs) are prominent regulators of key pathological processes leading to...
2.
Alizadeh F, Bozorgmehr A, Tavakkoly-Bazzaz J, Ohadi M
Mol Genet Genomics
. 2018 Jan;
293(3):747-752.
PMID: 29332164
Differential expansion of a number of human short tandem repeats (STRs) at the critical core promoter and 5' untranslated region (UTR) support the hypothesis that at least some of these...
3.
Zaimy M, Saffarzadeh N, Mohammadi A, Pourghadamyari H, Izadi P, Sarli A, et al.
Cancer Gene Ther
. 2017 Jun;
24(6):233-243.
PMID: 28574057
Cancer is one of the leading cause of death in the world with the prevalence of >10 million mortalities annually. Current cancer treatments include surgical intervention, radiation, and taking chemotherapeutic...
4.
Zaimy M, Jebali A, Bazrafshan B, Mehrtashfar S, Shabani S, Tavakoli A, et al.
Cancer Gene Ther
. 2016 Aug;
23(9):315-20.
PMID: 27514505
The aim of this study was to evaluate an engineered nanostructure to silence five important oncogenes, including BAG1, MDM2, Bcl-2, BIRC5 (survivin) and XIAP, in acute myeloid leukemia subtype 2...